My friends,
Without this forum, my GCA journey would have been entirely different. You have all been there to support me, educate me, and reinforce me when I thought I was sinking. It has always made me sad that TCZ is only available to GCA patients for one year, subject to review for an additional year's treatment.
I've been on it for five years and will be kept on it as a safeguard when and if I get off of prednisone. I would love to think this may make it more available to patients in the UK. Do you think it will?
I wonder what the rheumatologists there think, especially those working in research and study.💞
PS. These meds have been researched, of course, and approved by the FDA in the States. Their side effects and risks are the same as Actemra. With my monthly delivery, I get at least 12 sheets of caution...I knew them when I opted to take the drug.💞
TYENNE® (tocilizumab-aazg) is a prescription medicine called an interleukin-6 (IL-6) receptor antagonist.
TYENNE is used:
To treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease modifying antirheumatic drug (DMARD) has been used and did not work well
To treat adults with giant cell arteritis (GCA)
To treat patients with active polyarticular juvenile idiopathic arthritis (PJIA) 2 years of age and older
To treat patients with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older
but according to research Tyenne done for FDA approval for distribution in the states can be used for patients with GCA.
___________________________________________________________________________________________________________
The second one I am aware of, Tofidence , is not interchageable with Actemra, . The TOFIDENCE intravenous formulation is approved for the treatment of moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis. It is not available for at home injections at this point.